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Abstract 21 
Sporulation is a complex cell differentiation programme shared by many members of the 22 
Firmicutes, the end result of which is a highly resistant, metabolically inert spore that can 23 
survive harsh environmental insults. Clostridium difficile spores are essential for transmission 24 
of disease and are also required for recurrent infection. However, the molecular basis of 25 
sporulation is poorly understood, despite parallels with the well-studied Bacillus subtilis 26 
system. The spore envelope consists of multiple protective layers, one which is a specialised 27 
layer of peptidoglycan, called the cortex, that is essential for the resistant properties of the 28 
spore. We have identified and characterised a penicillin binding protein (PBP) that is required 29 
for cortex synthesis in C. difficile. Surprisingly this PBP was also found to contribute to 30 
cephalosporin resistance, indicating an additional role in the synthesis of vegetative cell wall. 31 
This is the first description of a cortex-specific PBP in C. difficile and begins the process of 32 
unravelling cortex biogenesis in this important pathogen. 33 
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Introduction 35 
C. difficile is the most common cause of nosocomial antibiotic-associated diarrhea, with an 36 
estimated 453,000 infections and 29,300 deaths per year in the USA alone (Lessa et al., 2015). 37 
C. difficile infection (CDI) requires prior disruption to the gut microbiota, most commonly due 38 
to an administered antibiotic (Smits et al., 2016). As current treatments largely rely on 39 
antibiotic therapy, with further consequent damage to the microbiota, recurrent disease is 40 
common and is associated with worse patient prognosis (Rupnik et al., 2009). In recent years 41 
there have been dramatic changes in C. difficile epidemiology, in particular due to the 42 
emergence of the epidemic ribotype 027 lineage, a previously rare ribotype that was 43 
responsible for a series of large hospital outbreaks in North America in the early years of this 44 
century before spreading worldwide (He et al., 2013). 45 
The spore is an absolute requirement for transmission of disease (Deakin et al., 2012), it allows 46 
the organism to transit the lethal aerobic environment while also providing significant 47 
resistance to desiccation, heat and common disinfectants (Dyer et al., 2019). As a result, the 48 
spores shed by an infected individual can survive in the environment for an extended period of 49 
time, a particular problem in hospital environments where large numbers of susceptible 50 
individuals are housed in close proximity. The process of sporulation is still relatively poorly 51 
understood, despite significant advances in recent years (Zhu et al., 2018). We have previously 52 
used high-density transposon mutagenesis and TraDIS to identify a subset of C. difficile genes 53 
required for formation of mature heat-resistance spores (Dembek et al., 2015). In total, 54 
transposon insertions in 798 genes were found to significantly impact sporulation, many with 55 
no clear homology to previously characterised proteins. Very few of these 798 genes have been 56 
studied in C. difficile but many have homologues in the well-studied Bacillus subtilis 57 
sporulation pathway. However, despite the clear parallels between sporulation in B. subtilis 58 
and C. difficile, there are enough critical differences to greatly reduce the value of assumptions 59 
based on homology (Paredes et al., 2005; Underwood et al., 2009; Fimlaid et al., 2013). The 60 
response regulator Spo0A is the master regulator of sporulation, phosphorylation of which sets 61 
in motion a complex asymmetric cell differentiation programme involving the sequential 62 
activation of a series of dedicated sigma factors that are in turn responsible for the expression 63 
of the individual regulons required for correct spore morphogenesis (Paredes-Sabja et al., 64 
2014). The result is the complex multi-layered spore structure that lends robustness to 65 
environmental insult. The spore consists of a dehydrated core surrounded by a membrane and 66 
peptidoglycan cell wall (primordial wall) derived from the mother cell envelope. Around this 67 
is a thick peptidoglycan cortex, synthesised during spore maturation, and a second membrane, 68 
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formed as a result of engulfment of the prespore by the mother cell. The outer surface consists 69 
of multiple layers of highly crosslinked proteins. The order and timing of synthesis of each of 70 
these layers is critical and disruption to any of the steps typically results in the formation of 71 
defective spores that lack full resistance properties (Fimlaid et al., 2013). 72 
In B. subtilis the peptidoglycan of the primordial wall and cortex differ in structure allowing 73 
differentiation by the cortex lytic hydrolases during germination (Gilmore et al., 2004). The 74 
primordial cell wall consists of typical alternating β-1→4-linked N-acetyl glucosamine and N-75 
acetyl muramic acid residues, crosslinked by 4-3 linked peptide stems attached to the muramic 76 
acid moieties, while in the cortex peptidoglycan every second N-acetyl muramic acid is 77 
modified to muramic-d-lactam, resulting in fewer stem peptides, fewer crosslinks and a more 78 
flexible overall structure (Meador-Parton and Popham, 2000). The class B penicillin binding 79 
protein (PBP) SpoVD is critical for synthesis of B. subtilis cortex (Daniel et al., 1994). During 80 
sporulation SpoVD is expressed in the mother cell where it interacts with the SEDS protein 81 
SpoVE to enable localisation to the asymmetric division septum (Fay et al., 2010). An N-82 
terminal transmembrane alpha helix anchors the protein in the membrane , placing the majority 83 
of the protein in the inter-membrane space where the cortex is ultimately synthesised (Sidarta 84 
et al., 2018). The protein consists of a PBP dimerization domain, followed by a transpeptidase 85 
domain and a penicillin-binding protein and serine/threonine kinase associated (PASTA) 86 
domain, the last of which is dispensable for cortex formation (Bukowska-Faniband and 87 
Hederstedt, 2015). 88 
C. difficile vegetative cell peptidoglycan is superficially similar to that of B. subtilis, albeit with 89 
a preponderance of 3-3 cross-linking as a result of L,D-transpeptidase activity (Peltier et al., 90 
2011). The structure of the C. difficile cortex peptidoglycan has not been determined, although 91 
it is assumed to contain muramic-d-lactam, and the enzymes required for cortex synthesis have 92 
not yet been characterised. Here we set out to identify and characterise the major C. difficile 93 
cortex PBP. 94 
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Methods 96 
Bacterial strains and growth conditions 97 
All bacterial strains, plasmids and oligonucleotides used in this study are described in Table 1. 98 
E. coli strains were routinely grown in LB broth and on LB agar, while C. difficile strains were 99 
grown in TY broth (Dupuy and Sonenshein, 1998) and on brain heart infusion agar. Cultures 100 
were supplemented with chloramphenicol (15 µg/ml), thiamphenicol (15 µg/ml) or cycloserine 101 
(250 µg/ml) as appropriate. 102 
 103 
Molecular biology methods 104 
Routine molecular biology techniques were performed according to the manufacturers 105 
protocols except where otherwise stated. PCR using Phusion High-Fidelity DNA Polymerase, 106 
plasmid isolation and purification of DNA fragments were performed using kits and reagents 107 
supplied by Thermo Fisher Scientific according to the manufacturer’s instructions. Restriction 108 
digestion, ligation and Gibson assembly were performed with enzymes supplied by New 109 
England Biolabs. Competent E. coli were transformed using standard methods and plasmid 110 
DNA was transferred to C. difficile as described previously (Kirk and Fagan, 2016). C. difficile 111 
mutants were constructed by homologous recombination as described previously (Cartman et 112 
al., 2012; Ng et al., 2013). Mutants were confirmed by PCR and Southern blotting using the 113 
Amersham ECL Direct Labelling and Detection System kit (GE) according to the 114 
manufacturer’s instructions. A 230 bp probe to the region immediately upstream of spoVD was 115 
generated by PCD using primer pair RF461/RF462. 116 
 117 
Plasmid construction 118 
pJAK032: pRPF150 was modified by inverse PCR using primer pair NF1957/NF1958 to 119 
introduce an XhoI site between the Strep Tag II and SecA2 coding sequences, yielding 120 
pJAK012. The Strep Tag II coding sequence was then excised using SacI and XhoI and 121 
replaced with a synthetic DNA fragment (IDT gBlock) consisting of a codon-optimized clip 122 
gene, modified by PCR with primer pair RF226/RF227 to add appropriate SacI and XhoI sites. 123 
pYAA024: Homology arms upstream and downstream of spoVD were amplified by PCR using 124 
oligonucleotide pairs RF68/RF139 and RF69/RF187. The resulting PCR products were joined 125 
together in a SOEing PCR reaction and cloned between the BamHI and SacI sites in pMTL-126 
YN4. 127 
pYAA027: spoVD expression appears to be driven from a promoter upstream of R20291_2545. 128 
In order to ensure complementation at wild type levels a fragment comprising 282 bp upstream 129 
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of R20291_2545, R20291_2545 itself and spoVD was amplified by PCR using primer pair 130 
RF324/RF325 and cloned between BamHI and SacI sites in pMTL-YN2C. 131 
pYAA031: secA2 in pJAK032 was replaced by spoVD. spoVD was amplified by PCR using 132 
primer pair RF374/RF375, digested with BamHI and XhoI and ligated to pJAK032 backbone 133 
cut with the same enzymes. 134 
pYAA047: 1,200 bp upstream of spoVD, the snap tag gene from pFT46 and the first 1,200 bp 135 
of spoVD were amplified by PCR using primer pairs, RF528/RF529, RF530/RF531 and 136 
RF532/RF533 respectively. pMTL-SC7215 was linearized by PCR using primer pair 137 
RF20/RF311. The four DNA fragments were then joined in a Gibson assembly reaction. 138 
pYAA048-050: The coding sequence of the SpoVD PBP dimerization domain (pYAA048; 139 
primers RF582/RF583), PASTA domain (pYAA049; primers RF584/RF585), or 140 
transpeptidase domain (pYAA050; primers RF586/RF587) were deleted by modification of 141 
pYAA031 by inverse PCR and subsequent recircularization by ligation.  142 
pYAA051: pYAA048 was further modified to delete the coding sequence of the PASTA 143 
domain by inverse PCR with primers RF584/RF585. 144 
 145 
Sporulation efficiency analysis 146 
Overnight cultures of C. difficile R20291 were diluted in BHI broth to an OD600nm of 0.01, 147 
incubated for 8 h at 37°C, diluted to an OD600nm of 0.0001 and finally incubated overnight. This 148 
allowed us to obtain cultures in stationary phase with no detectable spores (T=0). This culture 149 
was then incubated for 5 days with vegetative cells and spores enumerated daily. For total 150 
viable counts, 10-fold serial dilutions were spotted onto BHIS agar supplemented with 0.1% 151 
sodium taurocholate. For total spore counts, the same process was carried out following a 30 152 
min incubation at 65°C. Colonies were counted after 24 h incubation at 37°C and the assay was 153 
completed in biological triplicates. Formation of phase bright spores was also followed by 154 
phase-contrast microscopy at each time point. Samples fixed in 3.7% paraformaldehyde were 155 
imaged using a Nikon Eclipse Ti microscope and analysed using Fiji (Schindelin et al., 2012).  156 
 157 
Microscopy 158 
Bacterial samples were harvested by centrifugation, washed once with PBS and fixed in 4% 159 
paraformaldehyde. For phase contrast microscopy, samples were mounted in 80% glycerol and 160 
imaged using a Nikon Ti Eclipse inverted microscope. Samples for transmission electron 161 
microscopy were fixed as above before additional fixation in 3% glutaraldehyde, 0.1 M 162 
cacodylate buffer. Fixed samples were then treated with 1% OsO4, dehydrated in ethanol and 163 
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embedded in araldite resin. Embedded samples were sectioned at 85 nm on a Leica UC6 164 
ultramicrotome, transferred onto coated copper grids, further stained with uranyl acetate and 165 
lead citrate and visualized using a FEI Tecnai BioTWIN TEM at 80 kV fitted with a Gatan 166 
MS600CW camera.  167 
For fluorescence confocal microscopy, bacteria were grown in TY broth containing 500 nM 168 
HADA (Kuru et al., 2015), labelled with 250 nM SNAP-Cell TMR-Star (New England 169 
Biolabs) and grown under anaerobic conditions for a further 60 min. Following labelling, cells 170 
were harvested at 8,000 x g for 2 min at 4°C and washed twice in 1 ml ice cold PBS. Cells 171 
were resuspended in PBS and fixed in a 4% paraformaldehyde at room temperature for 30 min 172 
with agitation. Cells were washed three times in 1 ml ice cold PBS, immobilized by drying to 173 
a coverslip and mounted in SlowFade Diamond (Thermo Fisher Scientific). Images were 174 
captured using a Zeiss AiryScan confocal microscope. 175 
 176 
Antibiotic minimum inhibitory concentrations (MICs) 177 
MICs were determined using the agar dilution method based on the Clinical and Laboratory 178 
Standards Institute guidelines (Clinical and Laboratory Standards Institute, 2012). Briefly, agar 179 
plates were prepared with a range of concentrations of each antibiotic (2 µg/ml to 1024 µg/ml) 180 
using BHI supplemented with defibrinated horse blood (Oxoid) or Brazier’s CCEY agar plates 181 
(Bioconnections) supplemented with egg yolk emulsion (Oxoid) and defibrinated horse blood 182 
(Oxoid). The plates were dried at room temperature for 2 h and then pre-reduced in the 183 
anaerobic cabinet for 2 h. 100 µl of each C. difficile strain at an OD600nm of 0.5 was spread onto 184 
the plates. The plates were incubated for 48 h in the anaerobic cabinet at 37°C) and MICs were 185 
determined by reading the lowest antibiotic concentration on which the bacteria did not grow. 186 
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Results 188 
C. difficile produces a SpoVD homologue that is required for sporulation 189 
The C. difficile R20291 genome encodes 10 putative penicillin binding proteins (PBPs) (Table 190 
2) and one predicted monofunctional transglycosylase (CDR20291_2283). In our previous 191 
transposon mutagenesis study only two of these, CDR20291_0712 and 0985, were identified 192 
as essential for growth in vitro (Dembek et al., 2015). However, five of the PBPs were required 193 
for formation of heat-resistant spores, including two with homology to the B. subtilis cortex 194 
specific PBP SpoVD, CDR20291_1067 and 2544. Of these only CDR20291_2544 has the C 195 
terminal PASTA domain that is characteristic of the B. subtilis sporulation-specific PBPs 196 
(Bukowska-Faniband and Hederstedt, 2015). CDR20291_2544 (SpoVDCd) shares 40.1% 197 
amino acid identity with B. subtilis SpoVD and has the same predicted overall organisation, 198 
with an N terminal predicted transmembrane helix, followed by a PBP dimerization domain 199 
(PF03717), a transpeptidase domain (PF00905) and the C. terminal PASTA domain 200 
(PF03793). spoVD is located immediately downstream of CDR20291_2545 (Fig. 2A), 201 
encoding a protein with weak homology to B. subtilis FtsL (18.8% amino acid identity). 202 
Despite the weak similarity, the C. difficile and B. subtilis proteins are very similar in size (115 203 
and 117 amino acids respectively), have a similar PI (9.57 and 9.63 respectively) and both have 204 
a high proportion of lysine residues (22.6% and 14.5% respectively). CDR20291_2545 and 205 
spoVD appear to be in an operon, with the promoter upstream of CDR20291_2545. In our 206 
earlier TraDIS screen, CDR20291_2545 was also found to be required for sporulation, 207 
although this may have been due to polar effects on spoVD. 208 
 209 
To confirm a role in sporulation, we constructed a clean spoVD deletion by homologous 210 
recombination and then complemented this mutant by integrating the CDR20291_2545-spoVD 211 
cassette under the control of the native promoter into the chromosome between the pyrE and 212 
R20291_0189 genes (referred to here as R20291DspoVD pyrE::spoVD; Fig. 1A and B). We 213 
then analysed the ability of each strain to form heat-resistant spores. In our assay, a stationary 214 
phase culture of wild type R20291 gradually accumulated spores, accounting for 81% of the 215 
viable counts after 3 days (Fig 1C). In the same assay R20291DspoVD formed no detectable 216 
spores, even after 5 days of incubation (Fig 1D). Complementation completely restored 217 
sporulation to wild type levels (Fig 1E). Examination by phase contrast microscopy confirmed 218 
the presence of abundant mature phase bright spores in 5 day old cultures of wild type R20291 219 
and the complemented strain R20291DspoVD pyrE::spoVD (Fig. 2A). In contrast no phase 220 
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bright objects were observed in cultures of R20291DspoVD. When visualised at higher 221 
magnification using TEM of thin sections, no morphologically normal spores were observed 222 
in cultures of R20291DspoVD (Fig. 2B). Membrane-bound prespores were present, but these 223 
structures were irregular in shape and crucially lacked the cortex and protein coat layers seen 224 
in R20291 and the complemented strain developing spores. SpoVD is predicted to consist of 3 225 
domains: a PBP dimerization domain, a transpeptidase domain and a PASTA domain (Fig. 226 
3A). To identify which of these were required for viable spore formation, clip-spoVD was 227 
placed under the control of a constitutive promoter (Pcwp2) in a C. difficile expression vector 228 
and a panel of mutants, lacking one or more of these domains, were constructed (Table 1). 229 
These plasmids were all transferred into R20291DspoVD and the ability of the expressed 230 
SpoVD variant to restore sporulation was evaluated. Only proteins including both the 231 
dimerization and transpeptidase domains (SpoVD(DT) or full-length SpoVD(DTP)) restored 232 
normal sporulation (Fig. 3B), the PASTA domain was dispensable as observed previously in 233 
B. subtilis (Bukowska-Faniband and Hederstedt, 2015). This observation was supported by 234 
TEM examination, with morphologically normal spores only observed when the full-length or 235 
SpoVD(DT) proteins were expressed (not shown). 236 
 237 
B. subtilis SpoVD, and the wider family of class B PBPs, share a conserved active site 238 
consisting of 3 non-contiguous motifs that are brought into close proximity in the folded 239 
enzyme, SxxK, SxN and KTG (Sauvage et al., 2008). The first of these motifs contains the 240 
essential serine nucleophile. SpoVDCd has all three motifs, with Ser311 as the predicted 241 
nucleophile. SpoVD S311A supplied in trans was also incapable of complementing the 242 
sporulation defect observed in a spoVD deletion mutant (Fig. 3B), confirming a role for this 243 
residue in cortex synthesis. 244 
 245 
Subcellular localisation of SpoVD 246 
To visualise the cellular localisation of SpoVD, we fused the coding sequence for SNAP to the 247 
5¢ end of the spoVD gene and transferred this to the C. difficile genome in the native locus and 248 
under the control of the native promoter. SNAP was then labelled with the fluorescent reagent 249 
TMR-Start, while newly synthesised peptidoglycan was labelled with the fluorescent D-amino 250 
acid HADA (Kuru et al., 2015). Using Airyscan confocal microscopy we observed weak 251 
punctate fluorescence around the periphery of the cell, localizing to the asymmetric division 252 
septum once the cell had committed to sporulation (Fig. 4A). Fluorescence then tracked the 253 
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asymmetric membrane through engulfment (Fig. 4B and C), eventually surrounding the 254 
prespore (Fig. 4D). Localization of SNAP-SpoVD clearly preceded significant cortex synthesis 255 
as we visualised localisation around the spore without concomitant HADA accumulation (Fig. 256 
4D). Following further spore maturation (Fig. 4E), accumulation of new HADA-labelled 257 
peptidoglycan co-localized with SNAP-SpoVD. 258 
 259 
SpoVD is required for full resistance to cephalosporins 260 
A comparison of the peptidoglycan composition of wild type and DspoVD cells identified no 261 
obvious differences (not shown), suggesting that SpoVD is an exclusive cortex PBP. However, 262 
given the extensive complement of PBPs produced by C. difficile it is possible that a role in 263 
vegetative cell peptidoglycan synthesis could be masked. To determine if SpoVD did 264 
contribute to peptidoglycan synthesis more broadly we examined the susceptibility to two PBP-265 
targeting antibiotics, the second- and third-generation cephalosporins cefoxitin and 266 
ceftazidime, and the functionally unrelated antibiotic ciprofloxacin. Unsurprisingly deletion of 267 
spoVD had no effect on ciprofloxacin resistance (Table 3). This mutation did however increase 268 
susceptibility to cefoxitin and ceftazidime, decreasing the MIC 4-fold for each, with full 269 
resistance restore upon complementation (R20291DspoVD pyrE::spoVD). To identify which 270 
SpoVD domains were required for this resistance phenotype we complemented the DspoVD 271 
mutant with the same panel of SpoVD truncations described above (Table 3). Interestingly, 272 
mutant SpoVDs that lacked either the PBP Dimerization (SpoVD(TP)) or the PASTA domains  273 
(SpoVD(DT)) were still fully competent for restoring normal cephalosporin resistance, while 274 
that lacking the Transpeptidase domain (SpoVD(DP)) displayed the same aberrant sensitivity 275 
as the DspoVD mutant. This strongly suggests that only the Transpeptidase domain is required 276 
for full cephalosporin resistance. To test if the Transpeptidase alone was sufficient for 277 
resistance, we then constructed a truncation consisting of this domain alone. However, this 278 
construct did not restore resistance to wild type levels. A full-length SpoVD with a single 279 
amino acid substitution, replacing the putative nucleophilic serine with alanine 280 
(SpoVD(S311A)), also failed to restore resistance, demonstrating that enzymatic activity is 281 
required for the observed cephalosporin resistance. 282 
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Discussion 284 
C. difficile is the most common cause of hospital acquired infection in the USA and Europe 285 
(Magill et al., 2014; Aguado et al., 2015). The formation of a robust spore form is crucial for 286 
transmission of infection between patients and for persistence and relapse following treatment 287 
(Deakin et al., 2012). However, despite their importance in C. difficile pathogenesis, we still 288 
know surprisingly little about the underlying molecular mechanisms of sporulation and 289 
germination, in part due to a lack of effective genetic tools until recently (Shen, 2019). Much 290 
can be learned from the parallels with the well-studied but distantly related species B. subtilis, 291 
however there are significant differences in the sporulation pathways between the Bacillales 292 
and Clostridiales and even homologous proteins can play subtly different roles (Paredes et al., 293 
2005; Underwood et al., 2009; Fimlaid et al., 2013). Here we have identified and characterised 294 
a C. difficile homologue of the B. subtilis spore cortex PBP SpoVD. We have confirmed that 295 
this protein is required for sporulation in C. difficile and also identified a surprising role in 296 
resistance to cephalosporin antibiotics. 297 
 298 
Bioinformatic analysis of the C. difficile genome identified 10 genes encoding proteins with 299 
significant homology to characterised B. subtilis PBPs. In a previous transposon mutagenesis 300 
screen we determined that only two of these are essential for growth in vitro, but five were 301 
required for formation of heat-resistant spores (Dembek et al., 2015). One of these 302 
(R20291_2544) encodes a protein sharing 27.9% amino acid identity with B. subtilis SpoVD. 303 
Despite this relatively weak homology, the two proteins share a similar overall domain 304 
organisation and are encoded in a similar genomic context. To determine if this protein played 305 
a role in C. difficile sporulation we constructed a clean deletion mutant that we found to be 306 
incapable of producing viable spores. Microscopic examination of this mutant allowed us to 307 
visualise fully engulfed prespores but these structures lacked any obvious cortex. This 308 
sporulation defect was fully complemented by integration of spoVD (and the upstream 309 
R20291_2545 and native promoter) in a distal chromosomal locus. These observations clearly 310 
demonstrated that SpoVD plays a crucial role in C. difficile sporulation and is required for the 311 
synthesis of cortex peptidoglycan. We then demonstrated that the sporulation defect in a spoVD 312 
mutant could be complemented by expression in trans of a mutant SpoVD lacking the C 313 
terminal PASTA domain but that mutation of the PBP dimerization or transpeptidase domains 314 
resulted in a non-functional SpoVD. This is in full agreement with previous B. subtilis studies 315 
that showed that the PASTA domain was dispensable for cortex synthesis (Bukowska-316 
Faniband and Hederstedt, 2015). By comparison with the B. subtilis sequence we were also 317 
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able to putatively identify the active site nucleophile serine as S311 and confirmed this role by 318 
mutation to alanine, resulting in a non-functional SpoVD. 319 
 320 
It has been shown previously that B subtilis SpoVD localises to the asymmetric septum upon 321 
initiation of sporulation and ultimately to the developing spore following engulfment (Sidarta 322 
et al., 2018). To visualise this process in C. difficile we generated a strain expressing SNAP-323 
SpoVD under the control of the native promoter. Super-resolution fluorescence microscopy 324 
imaging of this strain showed clear localisation of SNAP-SpoVD to the asymmetric septum 325 
and to the developing spore. Intriguingly we also observed weak punctate fluorescence staining 326 
around the periphery of the mother cell. This could be indicative of mislocalisation as a result 327 
of the N terminal SNAP fusion or could suggest a broader role for SpoVD in vegetative cell 328 
peptidoglycan synthesis. To test this latter possibility, we examined the peptidoglycan 329 
composition of wild type and spoVD mutant cells but observed no obvious differences. Given 330 
the enormous potential for redundancy with 10 encoded PBPs it is possible that small 331 
differences could be missed in this analysis. To examine more subtle effects, we analysed 332 
resistance to two PBP-targeting cephalosporin antibiotics, cefoxitin and ceftazidime. 333 
Surprisingly the spoVD mutant displayed a 4-fold reduction in MIC to both antibiotics. 334 
Although small, this difference in MIC was reproducible and complemented perfectly when 335 
spoVD was added back. This unexpected observation strongly suggests that SpoVD is active 336 
in vegetative cells and is not spore-specific as has been suggested for B. subtilis.  337 
 338 
Sporulation of C. difficile represents one of the most pressing clinical challenges in tackling 339 
recurrent disease in individual patients as well as preventing outbreaks in nosocomial settings. 340 
However, this cell differentiation pathway also represents a promising target for the 341 
development of C. difficile-specific therapeutics. In order to exploit this potential we must first 342 
develop a deeper understanding of both the complex regulatory processes that underpin 343 
sporulation as well as the function of the effector proteins that direct differentiation. Here we 344 
have identified and characterised a PBP that is absolutely required for production of viable 345 
spores and that we believe is a promising target for future therapeutics aimed at preventing 346 
recurrent disease and transmission. 347 
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Tables 486 
 487 
Table 1: Strains, plasmids and oligonucleotides used in this study 488 
Strain Characteristics  Source 
R20291 C. difficile ribotype 027 strain isolated during 
an outbreak at Stoke Mandeville hospital, UK 
in 2006. 
(Stabler et al., 2009) 
R20291∆pyrE An R20291 pyrE deletion mutant. (Ng et al., 2013) 
R20291∆spoVD R20291 with the entire spoVD gene, except 
the first and last three codons, deleted. 
This study  
R20291∆spoVD 
pyrE::spoVD 
R20291ΔspoVD complemented by 
simultaneous restoration of the wild type 
pyrE gene and insertion of spoVD under the 
native promoter between pyrE and the 
downstream R20291_0189. 
This study  
R20291 snap-
spoVD 
R20291 with the native spoVD locus 
modified by homologus recombination to add 
the coding sequence of SNAP to the 5¢ end of 
spoVD. 
This study 
CA434 E. coli conjugative donor. HB101 carrying 
R702. 
(Purdy et al., 2002) 
NEB5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 
Φ80Δ (lacZ)M15 gyrA96 recA1 relA1 endA1 
thi-1 hsdR17. 
New England Biolabs 
   
Plasmid Characteristics Source 
pMTL960 E. coli-C. difficile shuttle vector. Nigel Minton 
pRPF150 Pcwp2-Strep-tag II-secA2 cassette cloned 
between KpnI and BamHI sites in 
pMTL960. 
(Fagan and Fairweather, 
2011) 
pJAK012 pRPF150 modified to introduce an XhoI site 
between Strep-tag II encoding sequence and 
the secA2 gene. 
This study 
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pJAK032 Strep Tag II coding sequence in pJAK012 
replaced with a codon-optimized clip gene. 
This study 
pFT46 Plasmid containing a C. difficile codon-
optimized copy of the snap gene under the 
control of a tetracycline inducible promoter. 
(Pereira et al., 2013) 
pMTL-YN4 Allele exchange vector for pyrE-based 
selection.  
(Ng et al., 2013) 
pMTL-YN2C pyrE restoration vector allowing 
simultaneous insertion of cargo DNA 
between pyrE and R20291_0189. 
(Ng et al., 2013) 
pMTL-SC7215 Allele exchange vector for codA-based 
selection. 
(Cartman et al., 2012) 
pYAA024 spoVD deletion: 1,200 bp homology arms 
representing the sequence upstream and 
downstream of R20291_2544 (spoVD) 
cloned into pMTL-YN4. Designed to delete 
all but the first and last 9 bp of spoVD. 
This study 
pYAA027 SpoVD complementation: spoVD and its 
native promoter cloned into pMTLYN2C. 
This study 
pYAA031 Constitutive CLIP-SpoVD: spoVD cloned 
between XhoI and BamHI sites in pJAK032. 
This study 
pYAA047 SNAP-SpoVD: 1,200 bp upstream of spoVD 
was fused to the coding sequence of SNAP 
and the first 1,200 bp of spoVD and the 
subsequent recombination cassette cloned 
into pMTL-SC7215. 
This study 
pYAA048 SpoVD(TP): pYAA031 modified by deletion 
of the sequence encoding the SpoVD PBP 
dimerization domain. 
This study 
pYAA049 SpoVD(DT): pYAA031 modified by 
deletion of the sequence encoding the SpoVD 
PASTA domain. 
This study 
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pYAA050 SpoVD(DP): pYAA031 modified by deletion 
of the sequence encoding the SpoVD 
transpeptidase domain. 
This study 
pYAA051 SpoVD(T): pYAA031 modified by deletion 
of the sequence encoding the SpoVD PBP 
dimerization and PASTA domains. 
This study 
pYAA052 His-SpoVD: spoVD cloned into pET-28a 
between NcoI and XhoI sites. 
This study 
   
Oligonucleotide Sequence Use 
NF1957 GAGTCAGTTATAGATTCGATACTTGA
C 
To introduce an XhoI 
site into pRPF150 by 
inverse PCR with 
NF1958 
NF1958 GAGTTTTTCAAATTGTGGATGACTCC
AC 
To introduce an XhoI 
site into pRPF150 by 
inverse PCR with 
NF1957 
RF20 AAACTCCTTTTTGATAATCTCATGAC
C 
To linearize pMTL-
SC7215 with RF311 
RF139* GTCAGAGCTCGTTCTTTATTTAGATTA
AATAAAGTCAATG  
To clone spoVD into 
pMTL-YN4 with RF187 
RF187* GTCAGGATCCCTTAGGAATCAGAGAG
TAGATAG 
To clone spoVD into 
pMTL-YN4 with RF139 
RF226 GATCGAGCTCGGAGGAACTACTATGG
ATAAAGATTGTGAAATGAAAAG 
To add a 5¢ SacI site 
onto a codon optimised 
clip gene fragment 
RF227 GATCCTCGAGAGCAGCTGCTCCTAAT
CCTGGTTTTCCTAATC 
To add 3xAla codons 
and a 3¢ XhoI site onto a 
codon optimised clip 
gene fragment 
RF311 TAGGGTAACAAAAAACACCG To linearize pMTL-
SC7215 with RF20 
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RF323* GTCAGGATCCGTTTATGGGTATATGT
TAATTATCTGTTAC 
To clone R20291_2545 
and spoVD into pMTL-
YN2C with RF324 
RF324* GTCAGAGCTCCTTAGGAATCAGAGAG
TAGATAG 
To clone R20291_2545 
and spoVD into pMTL-
YN2C with RF323 
RF374* GATCCTCGAGAGAAAAGTAAAGAGG
ATAAGTAAGAAAAGG 
To clone spoVD into 
pJAK032 with RF375 
RF375* GTCAGGATCCTTAGTTTTCAAAATAT
AGGGTTATACTTGAG   
To clone spoVD into 
pJAK032 with RF374 
RF461 CTCAAATCTATTCCCCCTAGTTATCC To amplify spoVD 
promoter probe with 
RF462 for Southern 
blotting 
RF462 GAATCTATGTGGTTATTCAAAAATCT
CG 
To amplify spoVD 
promoter probe with 
RF462 for Southern 
blotting 
RF528 aaatacggtgttttttgttaccctaagtttAAGCTAGAA
TAGATGGACC 
To amplify 1,200 bp 
homology arm upstream 
of spoVD 
RF529 acaatctttatccatATCTATTCCCCCTAGTTA
TCC 
To amplify 1,200 bp 
homology arm upstream 
of spoVD 
RF530 ctagggggaatagatATGGATAAAGATTGTG
AAATGAAGAGAACCAC 
To amplify snap 
RF531 cctctttacttttctAGCAGCTGCCCCAAGTCC To amplify snap 
RF532 cttggggcagctgctAGAAAAGTAAAGAGGA
TAAGTAAGAAAAG 
To amplify first 1,200 bp 
of spoVD 
RF533 tttggtcatgagattatcaaaaaggagtttTAAATCTAT
ACCTGTCTTATCCATAAG 
To amplify first 1,200 bp 
of spoVD 
RF582 TATATCTCTTGTTTGTTGTTCTAGTGC
TTTTG 
To delete the coding 
sequence of the SpoVD 
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PBP Dimerization 
domain with RF583 
RF583 GCAAAAAAGGTTACTGCAATAGCTAT
G 
To delete the coding 
sequence of the SpoVD 
PBP Dimerization 
domain with RF582 
RF584 GGTTTAACTCCCAAATATTTTAAAGA
GTCATTC 
To delete the coding 
sequence of the SpoVD 
PASTA domain with 
RF585 
RF585 TAAGGATCCACTAGTAACGGCC To delete the coding 
sequence of the SpoVD 
PASTA domain with 
RF584 
RF586 AGTATATAAAGAAGAAGAAAAAGCT
GAGTATG 
To delete the coding 
sequence of the SpoVD 
Transpeptidase domain 
with RF587 
RF587 ATTATTTAACTCATAAGCTTTCTGTAC
TGC 
To delete the coding 
sequence of the SpoVD 
Transpeptidase domain 
with RF586 
*Restriction endonuclease sites are underlined 489 
 490 
Table 2: Putative C. difficile PBPs. 491 
C. difficile R20291 
gene designation 
Best B. subtilis 
strain 168 hit 
Amino acid 
identity 
Essential in vitro? 
0712 PonA 27.3% Yes 
2544 SpoVD 40.1% No but required for 
sporulation 
1067 SpoVD 27.9% 
(PbpB 26.6%) 
No but required for 
sporulation 
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1131 DacF 43.8% No but required for 
sporulation 
1318 PbpX 21.3% 
(PbpE 20.4%) 
No 
2048 DacF 31.5% No but required for 
sporulation 
0441 DacF 30.3% No 
0985 PbpA 21.2% Yes 
3056 PbpX 20.1% No but required for 
sporulation 
2390 DacB 27.5% No 
 492 
Table 3: Antibiotic MICs (µg/ml). 493 
Strain Cefoxitin Ceftazidime Ciprofloxacin 
R20291 128 256 512 
R20291DspoVD 32 64 512 
R20291DspoVD pyrE::spoVD 128 256 512 
R20291DspoVD+SpoVD(DTP) 128 256 n.d. 
R20291DspoVD+SpoVD(TP) 128 256 n.d. 
R20291DspoVD+SpoVD(DT) 128 256 n.d. 
R20291DspoVD+SpoVD(DP) 32 64 n.d. 
R20291DspoVD+SpoVD(T) 32 64 n.d. 
R20291DspoVD+SpoVD(S311A) 32 64 n.d. 
 494 
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Figure legends 496 
 497 
Figure 1: Sporulation requires SpoVD. A. Genomic organisation of the native spoVD locus 498 
(WT), following deletion of the spoVD gene (D) and following complementation by insertion 499 
of R20291_2545 and spoVD between the pyrE and R20291_0189 genes (Comp). The locations 500 
of XmnI (X) and BsrGI (B) sites are indicated, as is the annealing site of the Southern blot 501 
probe. The length of the diagnostic restriction product containing the probe sequence is also 502 
shown below each locus diagram. B. Southern blot analysis of a spoVD mutant 503 
(R20291DspoVD), the wild type parental strain (R20291) and complemented strain 504 
(R20291DspoVD pyrE::spoVD). A DNA ladder is shown on the left hand side. The predicted 505 
fragment sizes and annealing site of the probe are shown in panel A. C.-E. Sporulation 506 
efficiencies of the wild type (C.), spoVD mutant (D.) and complemented strains (E.). Stationary 507 
phase cultures were incubated anaerobically for 5 days with samples taken daily to enumerate 508 
total colony forming units (CFUs) and spores, following heat treatment to kill vegetative cells. 509 
Experiments were performed in duplicate on biological triplicates with mean and standard 510 
deviation shown. The dotted horizontal line indicates the limit of detection of the experiment. 511 
 512 
Figure 2: Microscopic analysis of sporulation. Phase contrast light microscopy (A.) and 513 
negative stained TEM (B.) of the wild type parental strain (R20291), spoVD mutant 514 
(R20291DspoVD) and complemented strain (R20291DspoVD pyrE::spoVD). A. Cultures were 515 
imaged at day 5 of the sporulation assays shown in Figure 1. Spores are visible as ovoid phase 516 
bright objects i, while vegetative cells are phase dark bacilli. B. TEM imaging of developing 517 
spores clearly shows normal spore development in R20291 and R20291DspoVD pyrE::spoVD; 518 
the densely stained core surrounded by a thick, largely unstained cortex layer. Cultures of 519 
R20291DspoVD contained no morphologically normal developing spores, although fully 520 
engulfed prespores without a cortex (example shown) were common. 521 
 522 
Figure 3: The contribution of SpoVD domains to sporulation. A. The domain organisation of 523 
SpoVD showing Pfam predictions (El-Gebali et al., 2019). B. Sporulation efficiency of 524 
R20291, R20291DspoVD and R20291DspoVD complemented in trans using a plasmid 525 
expressing a series of mutant SpoVDs under the control of a constitutive promoter: full-length 526 
SpoVD (DTP); SpoVD lacking the PBP dimerization domain (TP), PASTA domain (DT), 527 
transpeptidase domain (DP) or both PBP dimerization and PASTA domains (T); SpoVD 528 
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lacking the active site nucleophile serine (S311A). Shown is the sporulation efficiency after 5 529 
days in broth culture, expressed as number of spores as a percentage of total viable CFUs. 530 
Experiments were conducted in duplicate on biological triplicates and mean and standard 531 
deviations are shown. 532 
 533 
Figure 4: Subcellular localisation of SpoVD. R20291 snap-spoVD was grown for 24 h in TY 534 
broth containing the fluorescent D-amino acid HADA (500 nM) to label de novo synthesised 535 
peptidoglycan. The bacteria were then further stained with SNAP-Cell TMR-Star (250 nM) to 536 
label SNAP-SpoVD, fixed, mounted in SlowFade Diamond mountant and imaged using a Zeiss 537 
AiryScan confocal microscope. Shown are representative cells demonstrating the sequential 538 
stages of sporulation: A. asymmetric septum placement, B., C. and D. early, mid and complete 539 
prespore engulfment respectively, E. spore maturation. 540 
 541 
 542 
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